New developments in cytomegalovirus prevention and management.

[1]  T. Merigan,et al.  A controlled trial of ganciclovir to prevent cytomegalovirus disease after heart transplantation. , 1992, The New England journal of medicine.

[2]  R. Schooley,et al.  SYMPTOMATIC CYTOMEGALOVIRUS DISEASE IN THE CYTOMEGALOVIRUS ANTIBODY SEROPOSITIVE RENAL TRANSPLANT RECIPIENT TREATED WITH OKT31,2 , 1992, Transplantation.

[3]  J. Meyers,et al.  Early treatment with ganciclovir to prevent cytomegalovirus disease after allogeneic bone marrow transplantation. , 1991, The New England journal of medicine.

[4]  J. Bartlett,et al.  Mortality in patients with the acquired immunodeficiency syndrome treated with either foscarnet or ganciclovir for cytomegalovirus retinitis , 1991 .

[5]  S. Pauker,et al.  Which renal transplant patients should receive cytomegalovirus immune globulin? A cost-effectiveness analysis. , 1991, Transplantation.

[6]  R. Milk,et al.  Prospective study of cytomegalovirus antigenemia in allograft recipients , 1991, Journal of clinical microbiology.

[7]  C. Gross,et al.  Pharmacologic basis for high-dose oral acyclovir prophylaxis of cytomegalovirus disease in renal allograft recipients , 1991, Antimicrobial Agents and Chemotherapy.

[8]  E. Petersen Extrapulmonary cytomegalovirus disease in transplant patients. , 1991, Transplantation proceedings.

[9]  H. Friedman,et al.  Effect of Towne live virus vaccine on cytomegalovirus disease after renal transplant. A controlled trial. , 1991, Annals of internal medicine.

[10]  D. Snydman,et al.  Final analysis of primary cytomegalovirus disease prevention in renal transplant recipients with a cytomegalovirus-immune globulin: comparison of the randomized and open-label trials. , 1991, Transplantation proceedings.

[11]  T. The,et al.  Cytomegalovirus‐specific antibodies to an immediate early antigen and a late membrane antigen and their possible role in controlling secondary cytomegalovirus infection , 1991, Clinical and experimental immunology.

[12]  M. Ho,et al.  Epidemiology of cytomegalovirus infections. , 1990, Reviews of infectious diseases.

[13]  S. Chou,et al.  Newer methods for diagnosis of cytomegalovirus infection. , 1990, Reviews of infectious diseases.

[14]  J. Grundy Virologic and pathogenetic aspects of cytomegalovirus infection. , 1990, Reviews of infectious diseases.

[15]  R. Rubin Impact of cytomegalovirus infection on organ transplant recipients. , 1990, Reviews of infectious diseases.

[16]  H. Balfour,et al.  Management of cytomegalovirus disease with antiviral drugs. , 1990, Reviews of infectious diseases.

[17]  D. Snydman,et al.  Cytomegalovirus immunoglobulins in the prevention and treatment of cytomegalovirus disease. , 1990, Reviews of infectious diseases.

[18]  Zaia Ja Epidemiology and pathogenesis of cytomegalovirus disease. , 1990 .

[19]  P. Murray,et al.  Comparison of culture and serology for the diagnosis of cytomegalovirus infection in kidney and liver transplant recipients. , 1990, The Journal of infectious diseases.

[20]  R. Rubin,et al.  Combined antibody and ganciclovir treatment of murine cytomegalovirus-infected normal and immunosuppressed BALB/c mice , 1989, Antimicrobial Agents and Chemotherapy.

[21]  F. M. van de Rijke,et al.  RAPID DETECTION OF HUMAN CYTOMEGALOVIRUS DNA IN PERIPHERAL BLOOD LEUKOCYTES OF VIREMIC TRANSPLANT RECIPIENTS BY THE POLYMERASE CHAIN REACTION , 1989, Transplantation.

[22]  H. Balfour,et al.  A randomized, placebo-controlled trial of oral acyclovir for the prevention of cytomegalovirus disease in recipients of renal allografts. , 1989, The New England journal of medicine.

[23]  J. Preiksaitis,et al.  The risk of cytomegalovirus infection in seronegative transfusion recipients not receiving exogenous immunosuppression. , 1988, The Journal of infectious diseases.

[24]  P. Griffiths,et al.  The status of CMV as a human pathogen , 1988, Epidemiology and Infection.

[25]  D. Emanuel,et al.  Selection of an intravenous immune globulin for the immunoprophylaxis of cytomegalovirus infections: an in vitro comparison of currently available and previously effective immune globulins. , 1987, Bone marrow transplantation.

[26]  A. Levey,et al.  Use of cytomegalovirus immune globulin to prevent cytomegalovirus disease in renal-transplant recipients. , 1987, The New England journal of medicine.

[27]  W. Britt,et al.  Primary Cytomegalovirus Infection in Pregnancy: Incidence, Transmission to Fetus, and Clinical Outcome , 1987 .

[28]  L. Matter,et al.  The risk of transmitting cytomegalovirus to patients receiving blood transfusions. , 1986, The Journal of infectious diseases.

[29]  F. Logerfo,et al.  A pilot trial of a novel cytomegalovirus immune globulin in renal transplant recipients. , 1984, Transplantation.

[30]  M. Hirsch,et al.  Glomerulopathy Associated with Cytomegalovirus Viremia in Renal Allografts , 1981 .

[31]  R. Rubin,et al.  Infection in the renal transplant recipient. , 1981, The American journal of medicine.

[32]  C. Prober,et al.  Prevention of transfusion-acquired cytomegalovirus infections in newborn infants , 1981 .

[33]  R. Whitley,et al.  Cytomegalovirus infection in patients with renal transplants: potentiation by antithymocyte globulin and an incompatible graft. , 1980, The Journal of infectious diseases.

[34]  G. Monif,et al.  Blood as a potential vehicle for the cytomegaloviruses. , 1976, American journal of obstetrics and gynecology.

[35]  J. Dowling,et al.  Cytomegalovirus Infection in Children Undergoing Open-Heart Surgery 1 , 1976, The Yale journal of biology and medicine.

[36]  C. Alford,et al.  Comparative serial virologic and serologic studies of symptomatic and subclinical congenitally and natally acquired cytomegalovirus infections. , 1975, The Journal of infectious diseases.

[37]  U. Krech,et al.  Cytomegalovirus Infections of Man , 1971 .

[38]  D. Snydman Prevention of cytomegalovirus disease with intravenous immune globulin , 1991 .

[39]  H. Balfour,et al.  Treatment of invasive cytomegalovirus disease in solid organ transplant patients with ganciclovir. , 1991, Transplantation.

[40]  W. Weimar,et al.  Cytomegalovirus infection and renal transplantation. , 1989, The Journal of antimicrobial chemotherapy.

[41]  R. Rubin Infection in the Renal and Liver Transplant Patient , 1988 .